Pacific Biosciences of California
NASDAQ: PACBMenlo Park, US · Delaware corporation · 2 known investors
Pacific Biosciences develops long-read DNA and RNA sequencing platforms and kits for genomics research, including whole genome, targeted, epigenetic, and RNA sequencing applications. The company serves research institutions, clinical laboratories, and diagnostic organizations in genomics and life sciences.
BiotechDeep TechMedical Devices
Founders & leadership
CO
Christian O. HenryExecutive
JE
Jeff EidelExecutive
SG
Susan G. KimExecutive
MV
Mark Van OeneExecutive
Board
WW
William W. EricsonBoard director
HA
Hannah A. ValantineBoard director
LS
Lucy ShapiroBoard director
DB
David BotsteinBoard director
JF
John F. MilliganBoard director
MM
Marshall MohrBoard director
RS
Randall S. LivingstonBoard director
KO
Kathy OrdonezBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$169.8M disclosed across 2 rounds · 2023
▶$84.8MraisedOct 2023 · 165 investors · Other TechnologyRule 506(b)
▶$84.8MraisedOct 2023 · 165 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Randall S. LivingstonDirector
- Kathy OrdonezDirector
- David MelineDirector
- John F. MilliganDirector
- David BotsteinDirector
- Christian O. HenryExecutive Officer, Director
- Susan KimExecutive Officer
- Hannah ValentineExecutive Officer
- William W. EricsonDirector
- Jeff EidelExecutive Officer
- Lucy A. ShapiroDirector
- Marshall MohrDirector
- Mark Van OeneExecutive Officer
- Offering amount
- $84.8M
- Amount sold
- $84.8M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$85MraisedAug 2023 · 47 investors · Other TechnologyRule 506(b)
▶$85MraisedAug 2023 · 47 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Hannah A. ValantineDirector
- Christian O. HenryExecutive Officer, Director
- Lucy ShapiroDirector
- Jeff EidelExecutive Officer
- David BotsteinDirector
- John F. MilliganDirector
- Marshall MohrDirector
- Susan G. KimExecutive Officer
- Randall S. LivingstonDirector
- Kathy OrdonezDirector
- William W. EricsonDirector
- Mark Van OeneExecutive Officer
- Offering amount
- $85M
- Amount sold
- $85M
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapPacb71 shared keywordsPacBio develops long-read DNA sequencing systems and kits, including its Revio and Sequel II platforms and HiFi/SMRT sequencing technology, for whole genome, targeted, epigenetic, and RNA sequencing. Its products serve genomics researchers and clinical and diagnostic research labs studying humans, plants, animals, and microbes.
Genomeweb38 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Seeking Alpha23 shared keywordsSeeking Alpha is a financial research platform that provides stock analysis, investment tools, and market coverage across asset classes to investors. The platform aggregates research from thousands of analysts and investors, offering ratings, articles, and investment ideas.
Tradingview20 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
Companies competing with Pacific Biosciences of California for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Pacific Biosciences of California do?
- Pacific Biosciences develops long-read DNA and RNA sequencing platforms and kits for genomics research, including whole genome, targeted, epigenetic, and RNA sequencing applications. The company serves research institutions, clinical laboratories, and diagnostic organizations in genomics and life sciences.
- Who are Pacific Biosciences of California's investors?
- Pacific Biosciences of California's investors include Dag Ventures, Kleiner Perkins.
- How much funding has Pacific Biosciences of California raised?
- Pacific Biosciences of California has disclosed $169.8M raised across 2 rounds.
- Where is Pacific Biosciences of California headquartered?
- Pacific Biosciences of California is headquartered in Menlo Park, US.